Use of caplacizumab in a child with refractory thrombotic thrombocytopenic purpura

被引：14
|
作者：
Bhoopalan, Senthil Velan [1 ]
Hankins, Jane [1 ]
George, James [2 ]
Ryder, Alex [3 ]
Onder, Ali Mirza [3 ]
Puri, Latika [1 ]
机构：
[1] St Jude Childrens Res Hosp, 262 Danny Thomas Pl, Memphis, TN 38105 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[3] Le Bonheur Childrens Hosp, Memphis, TN USA
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷 / 07期
关键词：
ADAMTS13; caplacizumab; refractory TTP; thrombocytopenia; TTP; vWF;
D O I：
10.1002/pbc.27737
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
    Scully, M.
    Cataland, S. R.
    Peyvandi, F.
    Coppo, P.
    Knobl, P.
    Hovinga, J. A. Kremer
    Metjian, A.
    de la Rubia, J.
    Pavenski, K.
    Callewaert, F.
    Biswas, D.
    De Winter, H.
    Zeldin, R. K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (04): : 335 - 346
  • [22] Prolonged Exposure to Caplacizumab as Rescue Therapy in Refractory Immune Thrombotic Thrombocytopenic Purpura
    Rodgers, George M.
    Berndt, Misa
    Fonteno, Megan
    Gilreath, Jeffrey A.
    JOURNAL OF BLOOD MEDICINE, 2023, 14 : 209 - 211
  • [23] Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment
    Palanques-Pastor, Tomas
    Megias-Vericat, Juan Eduardo
    Boso Ribelles, Virginia
    Gomez Segui, Ines
    Poveda Andres, Jose Luis
    ACTA HAEMATOLOGICA, 2022, 145 (01) : 72 - 76
  • [24] Correction to: Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use
    Hannah A. Blair
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2019, 35 : 459 - 459
  • [25] Successful use of a second course of caplacizumab in relapsed thrombotic thrombocytopenic purpura
    Shaffer, Jon
    Grove, Angela
    PLATELETS, 2022, 33 (05) : 790 - 791
  • [26] USE OF VINCRISTINE IN REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA
    LEVIN, M
    GRUNWALD, HW
    ACTA HAEMATOLOGICA, 1991, 85 (01) : 37 - 40
  • [27] Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab
    Sukumar, Senthil
    George, James N.
    Cataland, Spero R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (04) : E76 - E77
  • [28] Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura
    Hanlon, Ashley
    Metjian, Ara
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [29] Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura
    Goshua, George
    Sinha, Pranay
    Hendrickson, Jeanne E.
    Tormey, Christopher A.
    Bendapudi, Pavan
    Lee, Alfred Ian
    BLOOD, 2020, 136
  • [30] Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura
    Reid, Justin H.
    Durant, Karin M.
    Chen, Sheh-Li
    Perissinotti, Anthony J.
    King, Richard
    Khoriaty, Rami
    Marini, Bernard L.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (07) : 1695 - 1702
12345